Phibro Animal Health (PAHC) Amortization of Deferred Charges (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Amortization of Deferred Charges of $572000.0 for Q1 2026, little changed year-over-year from $572000.0 in Q1 2025, and little changed quarter-over-quarter from $572000.0 in Q4 2025.
Phibro Animal Health (PAHC) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends
Phibro Animal Health's Amortization of Deferred Charges history runs 14 years deep, the most recent figure standing at $572000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $572000.0; the TTM figure through Mar 2026 stood at $2.3 million (up 34.35% YoY), while the FY2025 annual figure was $2.0 million, up 93.75% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $572000.0, roughly flat from $572000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $572000.0 in Q1 2025, with the low at $147000.0 in Q1 2022.
- The 5-year median for Amortization of Deferred Charges is $260000.0 (2023), against an average of $340764.7.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges sank 33.48% in 2022, then surged 120.0% in 2025.
- Phibro Animal Health's Amortization of Deferred Charges stood at $179000.0 in 2022, then surged by 45.25% to $260000.0 in 2023, then jumped by 93.85% to $504000.0 in 2024, then advanced by 13.49% to $572000.0 in 2025, then changed by 0.0% to $572000.0 in 2026.
- Business Quant data shows PAHC's Amortization of Deferred Charges at $572000.0 in Q1 2026, $572000.0 in Q4 2025, and $572000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 572,000.00 |
| Mar 31, 2026 | 572,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Jun 30, 2025 | 572,000.00 |
| Jun 30, 2025 | 572,000.00 |
| Mar 31, 2025 | 572,000.00 |
| Mar 31, 2025 | 572,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |